EAM
SPRY icon

Everstar Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Everstar Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
33,732
+13,732
+69% +$118K 0.13% 157
2026
Q1 		$161K Hold
20,000
– – 0.09% 176
2025
Q4 		$233K Hold
20,000
– – 0.12% 158
2025
Q3 		$201K Buy
20,000
+5,000
+33% +$71.8K 0.11% 174
2025
Q2 		$262K Hold
15,000
– – 0.16% 156
2025
Q1 		$189K Buy
+15,000
New +$180K 0.13% 169

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Everstar Asset Management's SPRY Position: Q2 2026 in Review

Everstar Asset Management increased its ARS Pharmaceuticals (SPRY) stake by 69% in Q2 2026, buying an estimated $118K and bringing the position to 33,732 shares worth $270K. The position accounts for 0.13% of the portfolio, ranked #157.

Everstar Asset Management first reported a position in SPRY in Q1 2025 and has held it in 6 quarters since. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Everstar Asset Management held 33,732 shares of ARS Pharmaceuticals worth $270K as of Q2 2026.
  • Everstar Asset Management bought 13,732 ARS Pharmaceuticals shares in Q2 2026, an estimated $118K.
  • ARS Pharmaceuticals made up 0.13% of Everstar Asset Management's portfolio in Q2 2026, its #157 holding.
  • Everstar Asset Management first reported a position in ARS Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Everstar Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.